Literature DB >> 2866815

Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms.

N Mercuri, G Bernardi, P Calabresi, A Cotugno, G Levi, P Stanzione.   

Abstract

The mechanism by which dopamine (DA) decreases the amplitude of the EPSP-IPSP sequences evoked by cortical stimulation was investigated by means of electrophysiological and biochemical methods. Intracellular recordings indicate that DA decreases the amplitude of the excitatory and inhibitory events by reducing the increase in membrane conductance measured at the peaks of the EPSP-IPSP. The non-synaptic input resistance was not modified. In addition the catecholamine (+50/+200 nA balanced current) was shown to decrease the action of glutamate (-30/-80 nA balanced current) and GABA (+40/+100 nA balanced current) when iontophoretically applied. These observations suggest that DA interferes with the excitatory (glutamatergic) and inhibitory (GABAergic) transmission at the postsynaptic site in striatal neurons. However, the depression of cellular excitability elicited by DA could not be ascribed only to its interaction with synaptic transmission at the postsynaptic level. In fact the catecholamine also inhibited spike frequency driven by depolarizing pulses and decreased the depolarization-induced release of glutamate at the presynaptic site, as shown by biochemical experiments with striatal synaptosomal preparations. A neuromodulatory role of DA in the depression of the excitability of striatal neurons by presynaptic and postsynaptic mechanisms is suggested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866815     DOI: 10.1016/0006-8993(85)90954-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  A neurocomputational theory of the dopaminergic modulation of working memory functions.

Authors:  D Durstewitz; M Kelc; O Güntürkün
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

Review 2.  Striatal dopamine in motor activation and reward-mediated learning: steps towards a unifying model.

Authors:  J Wickens
Journal:  J Neural Transm Gen Sect       Date:  1990

3.  Complex sensory-motor sequence learning based on recurrent state representation and reinforcement learning.

Authors:  P F Dominey
Journal:  Biol Cybern       Date:  1995-08       Impact factor: 2.086

4.  D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance.

Authors:  S Hernández-López; J Bargas; D J Surmeier; A Reyes; E Galarraga
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

5.  Relationships between locomotor activation and alterations in brain temperature during selective blockade and stimulation of dopamine transmission.

Authors:  P L Brown; D Bae; E A Kiyatkin
Journal:  Neuroscience       Date:  2006-12-29       Impact factor: 3.590

6.  Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats.

Authors:  E A Kiyatkin; G V Rebec
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

7.  Interactions of glutamate and dopamine in a computational model of the striatum.

Authors:  R Kötter; J Wickens
Journal:  J Comput Neurosci       Date:  1995-09       Impact factor: 1.621

8.  Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement.

Authors:  L H Burns; B J Everitt; A E Kelley; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

9.  Dopamine receptor gene expression by enkephalin neurons in rat forebrain.

Authors:  C Le Moine; E Normand; A F Guitteny; B Fouque; R Teoule; B Bloch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

10.  Motor coordination deficits in mice lacking RGS9.

Authors:  Jacqueline Blundell; Chau V Hoang; Bryan Potts; Stephen J Gold; Craig M Powell
Journal:  Brain Res       Date:  2007-11-19       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.